Drugs / Alequel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02185183 | Jan 2008 → Jan 2010 | Crohn disease | Hadassah Medical Organization | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alequel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02185183 ↗ |
| Modality | Protein / enzyme biologic | “a mixture of proteins derived from the patient's bowel” NCT02185183 ↗ |
| Route | Oral | “Oral administration of Alequel” NCT02185183 ↗ |